- Report
- May 2025
- 196 Pages
Global
From €3183EUR$3,545USD£2,711GBP
€3537EUR$3,939USD£3,012GBP
- Report
- April 2025
- 175 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- April 2025
- 250 Pages
Global
From €4031EUR$4,490USD£3,433GBP
- Report
- August 2022
- 111 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- March 2024
- 150 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- April 2024
- 537 Pages
United States
From €7178EUR$7,995USD£6,113GBP
- Report
- August 2023
- 103 Pages
Global
From €3500EUR$4,176USD£3,085GBP
Brachytherapy is a type of radiation therapy used to treat cancer. It involves the placement of radioactive sources directly into or near a tumor. Brachytherapy devices are used to deliver radiation to the tumor, while minimizing exposure to surrounding healthy tissue. These devices are typically used to treat cancers of the prostate, breast, head and neck, and gynecological organs.
Brachytherapy devices are typically classified into two categories: high-dose rate (HDR) and low-dose rate (LDR). HDR devices are used to deliver a high dose of radiation in a short period of time, while LDR devices are used to deliver a lower dose of radiation over a longer period of time. Both types of devices are used to treat a variety of cancers.
The brachytherapy device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Varian Medical Systems, Elekta AB, C. R. Bard, Inc., IsoRay Medical, Inc., and Eckert & Ziegler BEBIG. Show Less Read more